• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期与延迟导线重新定位后心脏植入式电子设备感染的风险

Risk of Cardiac Implantable Electronic Device Infection after Early versus Delayed Lead Repositioning.

作者信息

Schvartz Noemi, Haidary Arian, Wakili Reza, Hecker Florian, Kupusovic Jana, Zsigmond Elod-Janos, Miklos Marton, Saghy Laszlo, Szili-Torok Tamas, Erath Julia W, Vamos Mate

机构信息

Cardiology Center/Cardiac Electrophysiology Division, Internal Medicine Clinic, University of Szeged, 6725 Szeged, Hungary.

Department of Cardiology, Division of Clinical Electrophysiology, Goethe University Hospital Frankfurt, 60596 Frankfurt am Main, Germany.

出版信息

J Cardiovasc Dev Dis. 2024 Apr 9;11(4):117. doi: 10.3390/jcdd11040117.

DOI:10.3390/jcdd11040117
PMID:38667735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11049932/
Abstract

(1) Background: Early reintervention increases the risk of infection of cardiac implantable electronic devices (CIEDs). Some operators therefore delay lead repositioning in the case of dislocation by weeks; however, there is no evidence to support this practice. The aim of our study was to evaluate the impact of the timing of reoperation on infection risk. (2) Methods: The data from consecutive patients undergoing lead repositioning in two European referral centers were retrospectively analyzed. The odds ratio (OR) of CIED infection in the first year was compared among patients undergoing early (≤1 week) vs. delayed (>1 week to 1 year) reoperation. (3) Results: Out of 249 patients requiring CIED reintervention, 85 patients (34%) underwent an early (median 2 days) and 164 (66%) underwent a delayed lead revision (median 53 days). A total of nine (3.6%) wound/device infections were identified. The risk of infection was numerically lower in the early (1.2%) vs. delayed (4.9%) intervention group yielding no statistically significant difference, even after adjustment for typical risk factors for CIED infection (adjusted OR = 0.264, 95% CI 0.032-2.179, = 0.216). System explantation/extraction was necessary in seven cases, all being revised in the delayed group. (4) Conclusions: In this bicentric, international study, delayed lead repositioning did not reduce the risk of CIED infection.

摘要

(1) 背景:早期再次干预会增加心脏植入式电子设备(CIED)感染的风险。因此,一些操作人员在导线脱位的情况下会将导线重新定位推迟数周;然而,没有证据支持这种做法。我们研究的目的是评估再次手术时机对感染风险的影响。(2) 方法:对两个欧洲转诊中心连续接受导线重新定位的患者数据进行回顾性分析。比较早期(≤1周)与延迟(>1周至1年)再次手术患者第一年CIED感染的比值比(OR)。(3) 结果:在249例需要CIED再次干预的患者中,85例(34%)接受了早期(中位时间2天)再次手术,164例(66%)接受了延迟导线修复(中位时间53天)。共发现9例(3.6%)伤口/设备感染。早期(1.2%)干预组的感染风险在数值上低于延迟(4.9%)干预组,即使在对CIED感染的典型风险因素进行调整后,差异也无统计学意义(调整后的OR = 0.264,95%CI 0.032 - 2.179,P = 0.216)。7例需要进行系统取出/拔除,均在延迟组进行了修复。(4) 结论:在这项双中心的国际研究中,延迟导线重新定位并未降低CIED感染的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae30/11049932/254d132f2425/jcdd-11-00117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae30/11049932/1bee904fdee1/jcdd-11-00117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae30/11049932/254d132f2425/jcdd-11-00117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae30/11049932/1bee904fdee1/jcdd-11-00117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae30/11049932/254d132f2425/jcdd-11-00117-g002.jpg

相似文献

1
Risk of Cardiac Implantable Electronic Device Infection after Early versus Delayed Lead Repositioning.早期与延迟导线重新定位后心脏植入式电子设备感染的风险
J Cardiovasc Dev Dis. 2024 Apr 9;11(4):117. doi: 10.3390/jcdd11040117.
2
Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices.经静脉拔除导线时机对感染性心脏植入式电子设备预后的影响
Heart Rhythm. 2022 May;19(5):768-775. doi: 10.1016/j.hrthm.2021.12.023. Epub 2021 Dec 27.
3
Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices.早期与延迟取出感染性心血管植入电子设备患者的心脏起搏器/除颤器。
JACC Clin Electrophysiol. 2021 Jun;7(6):755-763. doi: 10.1016/j.jacep.2020.11.003. Epub 2020 Dec 24.
4
Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study.心脏植入式电子设备 (CIED) 感染费用高昂,并与住院时间延长有关:英国回顾性观察研究。
PLoS One. 2019 Jan 2;14(1):e0206611. doi: 10.1371/journal.pone.0206611. eCollection 2019.
5
Safety and Efficacy of Submuscular Implantation With Resterilized Cardiac Implantable Electronic Device in Patients With Device Infection: A Retrospective Observational Study in Taiwan.重新消毒的心脏植入式电子设备肌下植入治疗设备感染患者的安全性和有效性:台湾一项回顾性观察研究
Open Forum Infect Dis. 2022 Apr 10;9(5):ofac100. doi: 10.1093/ofid/ofac100. eCollection 2022 May.
6
Early, Delayed and Late Cardiac Implantable Electronic Device Infections: Do the Timing of Onset and Pathogens Matter?早期、延迟和晚期心脏植入式电子设备感染:发病时间和病原体有影响吗?
J Clin Med. 2022 Jul 6;11(14):3929. doi: 10.3390/jcm11143929.
7
Cardiac surgery in patients with cardiac implantable electronic devices and risk of device infections: a nationwide nested case-control study.心脏植入式电子设备患者的心脏手术与器械感染风险:一项全国性巢式病例对照研究。
J Interv Card Electrophysiol. 2023 Jun;66(4):897-904. doi: 10.1007/s10840-022-01236-7. Epub 2022 May 2.
8
Long-term risk of cardiovascular implantable electronic device reinterventions following external cardioversion of atrial fibrillation and flutter: A nationwide cohort study.心房颤动和房扑行体外心脏转复后心血管植入式电子设备再干预的长期风险:一项全国性队列研究。
Heart Rhythm. 2023 Sep;20(9):1227-1235. doi: 10.1016/j.hrthm.2023.03.024. Epub 2023 Mar 23.
9
Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis.接受抗菌心血管植入式电子设备包膜患者的风险概况和结局:一项回顾性分析。
World J Cardiol. 2022 Mar 26;14(3):177-186. doi: 10.4330/wjc.v14.i3.177.
10
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.抗菌包膜与植入式心脏复律除颤器和心脏再同步治疗装置更换后的低感染率相关:Citadel 和 Centurion 研究的结果。
JACC Clin Electrophysiol. 2017 Oct;3(10):1158-1167. doi: 10.1016/j.jacep.2017.02.016. Epub 2017 May 31.

引用本文的文献

1
Anti-Methicillin-Resistant Efficacy of Layer-by-Layer Silver Nanoparticle/Polyacrylic Acid-Coated Titanium Using an In-House Dip Coater.使用自制浸涂机制备的层层银纳米颗粒/聚丙烯酸包覆钛对耐甲氧西林的抗菌效果
Polymers (Basel). 2025 Jan 25;17(3):333. doi: 10.3390/polym17030333.

本文引用的文献

1
Editorial: Developments in cardiac implantable electronic device therapy: how can we improve clinical implementation?社论:心脏植入式电子设备治疗的进展:我们如何改善临床应用?
Front Cardiovasc Med. 2023 Apr 19;10:1177882. doi: 10.3389/fcvm.2023.1177882. eCollection 2023.
2
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
3
Short- and Long-Term Risk of Lead Dislodgement Events: Real-World Experience From Product Surveillance Registry.
短期和长期的 Lead Dislodgement 事件风险:来自产品监测登记处的真实世界经验。
Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011029. doi: 10.1161/CIRCEP.122.011029. Epub 2022 Aug 4.
4
Antibiotic-Eluting Envelopes for the Prevention of Cardiac Implantable Electronic Device Infections: Rationale, Efficacy, and Cost-Effectiveness.用于预防心脏植入式电子设备感染的抗生素洗脱封套:原理、疗效及成本效益
Front Cardiovasc Med. 2022 Mar 28;9:855233. doi: 10.3389/fcvm.2022.855233. eCollection 2022.
5
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
6
Risk Stratifying and Prognostic Analysis of Subclinical Cardiac Implantable Electronic Devices Infection: Insight From Traditional Bacterial Culture.无症状性心脏植入式电子设备感染的风险分层和预后分析:传统细菌培养的见解。
J Am Heart Assoc. 2021 Nov 16;10(22):e022260. doi: 10.1161/JAHA.121.022260. Epub 2021 Nov 3.
7
Temporal and Microbiological Analysis of Cardiac Implantable Electrical Device Infections - A Retrospective Study.心脏植入式电子装置感染的时间和微生物学分析——一项回顾性研究
Circ Rep. 2021 Aug 21;3(9):488-496. doi: 10.1253/circrep.CR-21-0095. eCollection 2021 Sep 10.
8
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364.
9
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
10
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.利用医疗保健索赔来验证预防心律失常装置感染试验心脏植入式电子设备感染风险评分。
Europace. 2021 Sep 8;23(9):1446-1455. doi: 10.1093/europace/euab028.